Laparoscopic surgery for colorectal cancer
When compared to traditional open surgery, the recovery from a laparoscopic colectomy can be shorter and less uncomfortable.
What is laparoscopic surgery?
Laparoscopic surgery is a type of minimally invasive surgery. Instead of one large incision, the surgeon makes a few very small incisions (about ¼ to ½ inch) into the abdomen to insert a small surgical camera and instruments. A slightly bigger incision, about two inches wide, is made to remove the tumor and any other tissue.


Why have laparoscopic surgery?
Advantages to laparoscopic surgery versus open procedures include:
- Less recovery time
- Lower risk of infection
- Smaller scars
- Less pain and discomfort after surgery
- Shorter hospital stay
Speedier return to normal activities
Who is eligible for a laparoscopic colectomy?
Many colorectal cancer patients are good candidates for laparoscopic colectomy surgery.
The best option for you depends on several factors, including:
- your overall health
- your medical history
- your surgeon’s experience
- the cancer stage
- the cancer location
What happens during a laparoscopic surgery?
- Carbon dioxide gas is used to inflate the abdomen and create space for the surgeon to operate.
- The laparoscope (a small camera) sends video images from inside the body to monitors in the operating room.
- During the procedure, the surgeon moves the instruments by watching the monitors.
- The surgeon will remove the segment of the colon or rectum that contains the tumor through the larger incision.
Brittany's story: open versus laparoscopic surgery for colorectal cancer
This short video tells the story of Colorado resident Brittany Slater, whose life was turned upside-down by a colon cancer diagnosis at age 23. Her tale demonstrates the differences between an open procedure and a laparoscopic surgery.

Up Next
More about surgery optionsTop resources

A blood test that sees what scans can't
For many cancer patients, the end of active treatment brings a new kind of dread. Scans every few months and anxious waits for results. A blood test is changing that experience for a growing number of patients.

HAI therapy proves pivotal for pioneering patient
When Helen was diagnosed with metastatic colorectal cancer, the biggest concern for her medical team was that her cancer had spread to her liver. One type of therapy, hepatic artery infusion, offered a path forward, but there was a catch. Nobody at her hospital had ever done it before. She'd have to be first.

Where breakthroughs begin: Project Cure CRC spotlight on Dr. Lisa Mielke
hrough Project Cure CRC, the Alliance is fueling bold, early-stage research with the potential to transform colorectal cancer treatment. Dr. Lisa Mielke’s groundbreaking work explores how the gut’s immune system and nerve signaling influence cancer growth—opening the door to new therapeutic approaches, including repurposed existing drugs. This is what’s possible when promising ideas get the support they need to move forward.




